NIHR Maudsley BRC Blog

Our latest news and events

#BePartOfResearch campaign: Our activity

TrialBlazers, a two-week campaign led by the National Institute for Health and Care Research (NIHR), took place earlier this month. It recognised those who volunteer to take part in health and care research and called on people across the UK to take part in research. 

By NIHR Maudsley BRC at 31 May 2022

Making referrals to the AVATAR2 trial: An interview with Dr Helen Harding

The AVATAR2 trial is a multi-centre study of therapy aiming to help people who hear distressing voices by enabling them to build an avatar to represent the owner of the voice. Referrers play a pivotal role by recommending participants take part in the trial. Here Clinical Psychologist, Dr Helen Harding, talks about the referral process and how she sees the research benefitting patients in the short and long term. Dr Harding is a Clinical Psychologist in Lambeth Community Services.

By NIHR Maudsley BRC at 20 May 2022

Unplanned hospital admissions for people with dementia higher in the last year of life

New research from King’s College London found that people living with dementia experience higher levels of unplanned hospitals admissions towards the end of life after receiving their dementia diagnosis. The study found that 40% of all unplanned hospital admissions after a diagnosis of dementia took place in the last year of life.

By NIHR Maudsley BRC at 18 May 2022

Professor Peter Goadsby elected to the Fellowship of the Royal Society

Professor Peter Goadsby, Theme lead for Pain at the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre, has been elected to the Fellowship of the Royal Society, a Fellowship of many of the world’s most eminent scientists and the oldest academy in continuous existence.

By NIHR Maudsley BRC at 10 May 2022

NIHR Maudsley BRC researchers lead first study of psilocybin in adults with autism

Researchers from King’s College London and South London and Maudsley NHS Foundation Trust will be leading the first ever study of psilocybin in adults with autism spectrum disorder (ASD). 

By NIHR Maudsley BRC at 9 May 2022